Both sides of the coin

Hi all,

I am borrowing this idea from another poster on another thread.

I hold TIS at an average entry of about $0.29, I like the story and have a bit of personal skin in the game (no pun intended) as I have 2 brothers with diabetes.

Todays ann is great news that everything is apparently on track and we are ramping up to market this great product.

However, what are the possible road bumps/negative potential issues lying ahead. Don't get e wrong - I want Vitrogro in the shelves and the SP to take off but by discussing our thoughts on the potential negatives in the near short term we can share info./put these issues to bed and allay any concerns about TIS.

Not a bash or a down ramp.